126 related articles for article (PubMed ID: 32021803)
1. Early care of
Peoc'h K; Damaj L; Pelletier R; Lefèvre C; Dubourg C; Denis MC; Bendavid C; Odent S; Moreau C
Mol Genet Metab Rep; 2020 Mar; 22():100558. PubMed ID: 32021803
[No Abstract] [Full Text] [Related]
2. Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency.
Häberle J
Ther Clin Risk Manag; 2011; 7():327-32. PubMed ID: 21941437
[TBL] [Abstract][Full Text] [Related]
3. N-acetylglutamate synthase deficiency: an insight into the genetics, epidemiology, pathophysiology, and treatment.
Ah Mew N; Caldovic L
Appl Clin Genet; 2011; 4():127-35. PubMed ID: 23776373
[TBL] [Abstract][Full Text] [Related]
4. Presentation and management of N-acetylglutamate synthase deficiency: a review of the literature.
Kenneson A; Singh RH
Orphanet J Rare Dis; 2020 Oct; 15(1):279. PubMed ID: 33036647
[TBL] [Abstract][Full Text] [Related]
5. N-acetylglutamate synthase deficiency: Novel mutation associated with neonatal presentation and literature review of molecular and phenotypic spectra.
Al Kaabi EH; El-Hattab AW
Mol Genet Metab Rep; 2016 Sep; 8():94-8. PubMed ID: 27570737
[TBL] [Abstract][Full Text] [Related]
6. Favourable long-term outcome after immediate treatment of neonatal hyperammonemia due to N-acetylglutamate synthase deficiency.
Gessler P; Buchal P; Schwenk HU; Wermuth B
Eur J Pediatr; 2010 Feb; 169(2):197-9. PubMed ID: 19533169
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of Carbamylglutamate impacts the nutritional management of patients with N-Acetylglutamate synthase deficiency.
Singh RH; Bourdages MH; Kurtz A; MacLoed E; Norman C; Ratko S; van Calcar SC; Kenneson A
Orphanet J Rare Dis; 2024 Apr; 19(1):168. PubMed ID: 38637895
[TBL] [Abstract][Full Text] [Related]
8. Partial N-acetyl glutamate synthase deficiency presenting as postpartum hyperammonemia: Diagnosis and subsequent pregnancy management.
Abou Haidar L; Pachnis P; Gotway GK; Ni M; DeBerardinis RJ; McNutt MC
JIMD Rep; 2023 Nov; 64(6):403-409. PubMed ID: 37927481
[TBL] [Abstract][Full Text] [Related]
9. A novel UPLC-MS/MS based method to determine the activity of N-acetylglutamate synthase in liver tissue.
Dercksen M; Duran M; IJlst L; Kulik W; Ruiter JP; van Cruchten A; Tuchman M; Wanders RJ
Mol Genet Metab; 2016 Dec; 119(4):307-310. PubMed ID: 27771289
[TBL] [Abstract][Full Text] [Related]
10. Carglumic acid for the treatment of N-acetylglutamate synthase deficiency and acute hyperammonemia.
Häberle J
Expert Rev Endocrinol Metab; 2012 May; 7(3):263-271. PubMed ID: 30780843
[TBL] [Abstract][Full Text] [Related]
11. Datamining approaches for examining the low prevalence of N-acetylglutamate synthase deficiency and understanding transcriptional regulation of urea cycle genes.
Caldovic L; Ahn JJ; Andricovic J; Balick VM; Brayer M; Chansky PA; Dawson T; Edwards AC; Felsen SE; Ismat K; Jagannathan SV; Mann BT; Medina JA; Morizono T; Morizono M; Salameh S; Vashist N; Williams EC; Zhou Z; Morizono H
J Inherit Metab Dis; 2023 Oct; ():. PubMed ID: 37847851
[TBL] [Abstract][Full Text] [Related]
12. Normal Neurological Development During Infancy Despite Massive Hyperammonemia in Early Treated NAGS Deficiency.
Reigstad H; Woldseth B; Häberle J
JIMD Rep; 2017; 37():45-47. PubMed ID: 28275973
[TBL] [Abstract][Full Text] [Related]
13. Null mutations in the N-acetylglutamate synthase gene associated with acute neonatal disease and hyperammonemia.
Caldovic L; Morizono H; Panglao MG; Cheng SF; Packman S; Tuchman M
Hum Genet; 2003 Apr; 112(4):364-8. PubMed ID: 12594532
[TBL] [Abstract][Full Text] [Related]
14. Noncoding sequence variants define a novel regulatory element in the first intron of the N-acetylglutamate synthase gene.
Häberle J; Moore MB; Haskins N; Rüfenacht V; Rokicki D; Rubio-Gozalbo E; Tuchman M; Longo N; Yandell M; Andrews A; AhMew N; Caldovic L
Hum Mutat; 2021 Dec; 42(12):1624-1636. PubMed ID: 34510628
[TBL] [Abstract][Full Text] [Related]
15. A rare urea cycle disorder in a neonate: N-acetylglutamate synthetase deficiency.
Olgac A; Kasapkara ÇS; Kilic M; Emine Derinkuyu B; Azapagasi E; Kesici S; Biberoğlu G; Ozyazici A; Karaca M; Haberle J
Arch Argent Pediatr; 2020 Dec; 118(6):e545-e548. PubMed ID: 33231058
[TBL] [Abstract][Full Text] [Related]
16. N-acetylglutamate synthase deficiency and the treatment of hyperammonemic encephalopathy.
Elpeleg O; Shaag A; Ben-Shalom E; Schmid T; Bachmann C
Ann Neurol; 2002 Dec; 52(6):845-9. PubMed ID: 12447942
[TBL] [Abstract][Full Text] [Related]
17. A novel biochemically salvageable animal model of hyperammonemia devoid of N-acetylglutamate synthase.
Senkevitch E; Cabrera-Luque J; Morizono H; Caldovic L; Tuchman M
Mol Genet Metab; 2012 Jun; 106(2):160-8. PubMed ID: 22503289
[TBL] [Abstract][Full Text] [Related]
18. Mutations and polymorphisms in the human N-acetylglutamate synthase (NAGS) gene.
Caldovic L; Morizono H; Tuchman M
Hum Mutat; 2007 Aug; 28(8):754-9. PubMed ID: 17421020
[TBL] [Abstract][Full Text] [Related]
19. N-Acetylglutamate Synthase Deficiency Due to a Recurrent Sequence Variant in the N-acetylglutamate Synthase Enhancer Region.
Williams M; Burlina A; Rubert L; Polo G; Ruijter GJG; van den Born M; Rüfenacht V; Haskins N; van Zutven LJCM; Tuchman M; Saris JJ; Häberle J; Caldovic L
Sci Rep; 2018 Oct; 8(1):15436. PubMed ID: 30337552
[TBL] [Abstract][Full Text] [Related]
20. Understanding N-Acetyl-L-Glutamate Synthase Deficiency: Mutational Spectrum, Impact of Clinical Mutations on Enzyme Functionality, and Structural Considerations.
Sancho-Vaello E; Marco-Marín C; Gougeard N; Fernández-Murga L; Rüfenacht V; Mustedanagic M; Rubio V; Häberle J
Hum Mutat; 2016 Jul; 37(7):679-94. PubMed ID: 27037498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
